First-line treatment of women with advanced ovarian cancer: focus on bevacizumab

by Marchetti C, Muzii L, Romito A, Benedetti Panici P
Published 2019-02-01

Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches

by Palaia I, Tomao F, Sassu CM, Musacchio L, Benedetti Panici P
Published 2020-06-01

Current status of bevacizumab in advanced ovarian cancer

by Tomao F, Papa A, Rossi L, Caruso D, Benedetti Panici P, Venezia M, Tomao S
Published 2013-07-01

Angiogenesis and antiangiogenic agents in cervical cancer

by Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, Benedetti Panici P, Tomao S
Published 2014-12-01

First-Line Treatment  with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research

by Tomao F, Boccia SM, Sassu CM, Chirra M, Palaia I, Petrella MC, Di Donato V, Colombo N, Benedetti Panici P
Published 2020-07-01

Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review

by Marchetti C, Palaia I, Giorgini M, De Medici C, Iadarola R, Vertechy L, Domenici L, Di Donato V, Tomao F, Muzii L, Benedetti Panici P
Published 2014-07-01

PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives

by Musacchio L, Caruso G, Pisano C, Cecere SC, Di Napoli M, Attademo L, Tambaro R, Russo D, Califano D, Palaia I, Muzii L, Benedetti Panici P, Pignata S
Published 2020-07-01